文章基本信息

标题：Trends in HIV-2 Diagnoses and Use of the HIV-1/HIV-2 Differentiation Test — United States, 2010–2017
本地全文：下载
作者：Anne H. Peruski ; Laura G. Wesolowski ; Kevin P. Delaney 等
期刊名称：Morbidity and Mortality Weekly Report
出版年度：2020
卷号：69
期号：3
页码：63-66
DOI：10.15585/mmwr.mm6903a2
出版社：Centers for Disease Control and Prevention
摘要：What is already known about this topic? Since 2014, CDC has recommended using an antibody-based HIV-1/HIV-2 differentiation test as part of a laboratory-based algorithm to confirm HIV-1 and HIV-2 infections. What is added by this report? During 2010–2017, use of the HIV-1/HIV-2 differentiation test increased, but the number of confirmed HIV-2 diagnoses remained <0.1%. In addition, the overall number of false positive HIV-2 test results produced by the HIV-1/HIV-2 differentiation increased. What are the implications for public health practice? CDC recommends that laboratories continue to follow the laboratory-based algorithm with the HIV-1/HIV-2 differentiation test as the second step. However, updates to the laboratory-based testing algorithm merit consideration in the United States where HIV-2 infections remain rare.
关键词：HIV Diagnoses;HIV Testing;HIV-2;HIV Testing In The Laboratory;HIV Testing Recommendations;HIV/AIDS;HIV Prevention;MMWR;Morbidity & Mortality Weekly Report